Gold, L. S., Lebwohl, M. G., Bhatia, N., Lin, T. and Pillai, R. (2019) “Long-Term Management of Moderate-to-Severe Plaque Psoriasis: Maintenance of Treatment Success Following Cessation of Fixed Combination Halobetasol Propionate 0.01% And Tazarotene 0.045% (HP/TAZ) Lotion”, SKIN The Journal of Cutaneous Medicine, 3, p. S31. doi: 10.25251/skin.3.supp.31.